Business Segments Lotus Pharmaceutical Co., Ltd.

Equities

1795

TW0001795003

Pharmaceuticals

End-of-day quote Taiwan S.E. 2024-09-11 5-day change 1st Jan Change
270.50 TWD -2.70% Intraday chart for Lotus Pharmaceutical Co., Ltd. -1.28% -0.55%

Sales 2023 by Business Segment

See more © MarketScreener.com

Sales 2023 by Geography

See more © MarketScreener.com

Historical Breakdown of Revenue by Business Segments

Operating Income: Breakdown by Business Segment

Breakdown by Business Segment
Fiscal Period: December2014201520162017201820192020202120222023

Pharmaceutical Products

          

Pharmaceuticals Segment

9.11B 10.54B 12.53B 14.5B 16.86B

Total Assets

- - 21.53B 29.64B 32.84B

Operating Income

1.06B 1.58B 2.29B 4.11B 4.87B

Pharmaceutical Contract Research Organization

          

Others

242M 259M 236M 301M 339M

Total Assets

- - 440M 594M 845M

Operating Income

70.34M 33.82M 4.96M 2.48M 31.23M

Foreign

- - - - -

Operating Income

- - - - -

Domestic

- - - - -

Operating Income

- - - - -

Elimination

-176M -72.9M -113M -171M -245M

Total Assets

- - -744M -709M -697M

Operating Income

-14.1M -4.36M 3.27M -3.26M 659K

Geographical Revenue Distribution History

Geographical breakdown of sales
Fiscal Period: December2014201520162017201820192020202120222023

United States

2.69B 3.23B 4.45B 5.92B 6.81B

Total Assets

- - - - 1.27B

South Korea

5.04B 5.11B 5.25B 5.28B 5.59B

Total Assets

3.52B 3.21B 2.62B 2.12B 1.98B

Taiwan

826M 862M - - 2.41B

Total Assets

2.13B 2.62B 3.59B 7.74B 7.54B

Others

622M 1.53B 2.95B 3.44B 2.14B

Total Assets

53.96M 467M 481M 788M 262M
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW